AU2016202510A1 - Pharmaceutical composition of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof - Google Patents

Pharmaceutical composition of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof

Info

Publication number
AU2016202510A1
AU2016202510A1 AU2016202510A AU2016202510A AU2016202510A1 AU 2016202510 A1 AU2016202510 A1 AU 2016202510A1 AU 2016202510 A AU2016202510 A AU 2016202510A AU 2016202510 A AU2016202510 A AU 2016202510A AU 2016202510 A1 AU2016202510 A1 AU 2016202510A1
Authority
AU
Australia
Prior art keywords
difluorobenzo
cyclopropanecarboxamide
methylpropan
dioxol
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016202510A
Inventor
Rossitza Gueorguieva Alargova
Craig Antony Dunbar
Irina Nikolaevna Kadiyala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vertex Pharmaceuticals Inc
Original Assignee
Vertex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Inc filed Critical Vertex Pharmaceuticals Inc
Publication of AU2016202510A1 publication Critical patent/AU2016202510A1/en
Abandoned legal-status Critical Current

Links

AU2016202510A 2010-08-23 2016-04-20 Pharmaceutical composition of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof Abandoned AU2016202510A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61/375,976 2010-08-23
US61/506,220 2011-07-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2015202975A Division AU2015202975B2 (en) 2010-08-23 2015-06-03 Pharmaceutical composition of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof

Publications (1)

Publication Number Publication Date
AU2016202510A1 true AU2016202510A1 (en) 2016-05-12

Family

ID=

Similar Documents

Publication Publication Date Title
HK1209318A1 (en) Pharmaceutical compositions of (r)-1-(2,2- diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6- fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof (r)-1-(22-[d][13]-5-)-n-(1-(23-)-6--2- (1--2--2-)-1 --5-)
IL288388A (en) Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihyderoxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
IL251662A0 (en) Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
IL276157A (en) Pharmaceutical compositions and related methods of delivery
NZ606805A (en) Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof
IL199853A (en) Substituted derivatives of 5-hydroxy-adamantyl-2-yl and pharmaceutical compositions comprising them
IL196280A0 (en) Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
EP2331072B8 (en) Methods and compositions for oral administration of proteins
TWI562992B (en) Indazole derivative, pharmaceutical composition thereof, and use thereof as inhibitors of kinase activity
IL207202A (en) Cyclic azaindole-3-carboxamides, process for their preparation, pharmaceutical compositions comprising them and their use for manufacture of medicaments
EP2285215A4 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
AU2016202510A1 (en) Pharmaceutical composition of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof
SI1873140T1 (en) New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them
PL381535A1 (en) New connection containing derivative of taxane, pharmaceutical coposition and application